Delivery Order SPE2DB22D2005-SPE2DB25FJNF2
- Not listed
- The Defense Logistics Agency awarded a $14,099.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Ozempic 1 mg/dose (4 mg/3 ml) in 3ml vials, with an ultimate completion date of September 15, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain. The delivery will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,004.33 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitive award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price transaction with no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded a $31,772.81 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with an ultimate completion date of July 17, 2025. This competitive award, issued on July 16, 2025, carries a firm fixed price and involves no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary distribution and pharmaceutical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,947.43 for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with an ultimate completion date of August 1, 2025. This firm fixed price contract, awarded on July 31, 2025, represents a competitive award with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $6,445.20 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of July 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with the agency. The product will be delivered to the company's place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a $7,513.23 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials, with a completion date of September 15, 2025. The contract was competitively awarded on September 12, 2025, with firm fixed pricing and no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $7,916.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This non-set-aside competitive award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this transaction. The delivery order represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $7,035.96 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials under a firm fixed-price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $6,570.23 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed-price delivery order with an ultimate completion date of May 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,407.97 for Ozempic 1 mg/dose (4 mg/3 mL) vials on June 4, 2025, with a completion date of June 5, 2025. This firm fixed-price, competitively awarded delivery order represents a small-value pharmaceutical transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The place of performance is AmerisourceBergen's corporate...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJNF2Delivery Order
The Defense Logistics Agency awarded a $7,854.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with an ultimate completion date of June 5, 2025. This non-set-aside competitive award leverages AmerisourceBergen's extensive pharmaceutical distribution capabilities to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen has demonstrated consistent capability to meet federal procurement requirements through open competition across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 6/4/25 |